Annals of Thoracic Medicine Official publication of the Saudi Thoracic Society, affiliated to King Saud University
 
Search Ahead of print Current Issue Archives Instructions Subscribe e-Alerts Login 
Home Email this article link Print this article Bookmark this page Decrease font size Default font size Increase font size

    Article Cited by others

ORIGINAL ARTICLE

Erlotinib in wild type epidermal growth factor receptor non-small cell lung cancer: A systematic review

Jazieh Abdul-Rahman, Al Sudairy Reem, Abu-Shraie Nada, Al Suwairi Wafaa, Ferwana Mazen, Murad M Hassan

Year : 2013| Volume: 8| Issue : 4 | Page no: 204-208

   This article has been cited by
 
1 The HSP90 inhibitor ganetespib potentiates the antitumor activity of EGFR tyrosine kinase inhibition in mutant and wild-type non-small cell lung cancer
Donald L. Smith,Jaime Acquaviva,Manuel Sequeira,John-Paul Jimenez,Chaohua Zhang,Jim Sang,Richard C. Bates,David A. Proia
Targeted Oncology. 2015; 10(2): 235
[Pubmed]  [Google Scholar] [DOI]
2 S100A4 Is an Independent Prognostic Factor for Patients with Lung Cancer: A Meta-Analysis
Hao Bai,Jia-Lin Qian,Bao-Hui Han
Genetic Testing and Molecular Biomarkers. 2014; 18(5): 371
[Pubmed]  [Google Scholar] [DOI]

 

Read this article